AbbVie Limited
유한회사 ((유)) · Seoul, South Korea · LEI 254900ICOJABG3PWCE35
LEI lapsed
Summary
AbbVie Limited is registered in South Korea and entered in the “Corporation registration” under number 110111-4821818. Its legal form is 유한회사 ((유)). According to GLEIF, its ultimate parent is ABBVIE INC. (United States), which is also its direct parent. That group has 64 subsidiaries with LEIs in 37 countries, 1 of them in South Korea. The LEI was first issued on 9 Jul 2021 and the record was last updated on 9 Jul 2022. It has lapsed: renewal was due by 9 Jul 2022. AssetCensus found 3 data-quality notes for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 9 Jul 2022 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
- The ultimate-parent link rests on accounts for the period ending 31 Dec 2021, more than 24 months before this data release. The group may have changed since.
- The ultimate-parent relationship record was not renewed; it was last updated on 10 Nov 2025.
Company details
| Legal form | 유한회사 ((유)) |
|---|---|
| Register | Corporation registration · Register website |
| Registration number | 110111-4821818 |
| Registration authority | Supreme Court Registry |
| Jurisdiction | South Korea |
| Registered address | Samtan Bldg.-6F, 421, Yeong-daero, 06182 Seoul, South Korea |
| Headquarters address | Samtan Bldg.-6F, 06182 Gangnam-Ku Seoul, South Korea |
| Category | company or other legal entity |
| Status | active |
| LEI | 254900ICOJABG3PWCE35 |
| LEI status | lapsed |
| LEI first issued | 9 Jul 2021 |
| LEI record last updated | 9 Jul 2022 |
| Next LEI renewal | 9 Jul 2022 |
| Corroboration of the LEI record | fully corroborated |
Group membership
AbbVie Limited this entity
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | ABBVIE INC. | ABBVIE INC. |
| Accounting period | 1 Jan 2021 to 31 Dec 2021 | 1 Jan 2021 to 31 Dec 2021 |
| Evidence | other official documents | other official documents |
| Corroboration | supplied by the entity only | supplied by the entity only |
| Accounting standard | US GAAP | US GAAP |
| Relationship start | 31 Dec 2012 | 31 Dec 2012 |
| Recorded at GLEIF since | 12 Jul 2021 | 12 Jul 2021 |
| Last updated | 10 Nov 2025 | 10 Nov 2025 |
| Record status | not renewed | not renewed |
Other subsidiaries of the same direct parent (59)
- AbbVie A/S Denmark lapsed
- AbbVie AG Switzerland lapsed
- AbbVie AS Norway lapsed
- AbbVie B.V. Netherlands lapsed
- AbbVie Bahamas Ltd. Bahamas lapsed
- AbbVie Biopharmaceuticals GmbH Switzerland
- ABBVIE BIOTECHNOLOGY LTD Bermuda
- AbbVie Central Finance B.V. Netherlands
- AbbVie Corporation Canada
- ABBVIE D.O.O. Slovenia lapsed
- AbbVie Deutschland GmbH And Co. KG Germany lapsed
- Abbvie Endocrine Inc. United States lapsed